Atrial fibrillation and COPD commonly co-occur, and greater awareness, timelier diagnosis using spirometry, and guideline-directed management may improve outcomes for people with both diseases.
What is the role of spirometry in the diagnosis and management of co-occurring atrial fibrillation and COPD?
Greater awareness and timely diagnosis using spirometry in patients with co-occurring AF and COPD may improve outcomes and reduce stroke risk.
INTRODUCTION: People with COPD rarely have COPD alone, and the commonest co-morbidities occurring with COPD are cardiovascular. Whilst multiple studies have explored the association between major cardiovascular events and COPD, less attention has been paid to arrhythmias, specifically atrial fibrillation (AF). AF and COPD frequently occur together, posing challenges in diagnosis and management. In this review, we describe the relationship between AF and COPD epidemiologically and physiologically, demonstrating the role of spirometry as a diagnostic and disease management tool. AREAS COVERED: We provide epidemiological evidence that COPD and AF are independent risk factors for one another, that either disease is highly prevalent amongst people with the other, and that they have shared risk factors; all of which contribute to adverse prognostic. We elucidated common pathophysiological mechanisms implicated in AF-COPD. We ultimately present the epidemiological and physiological evidence with a view to highlight specific areas where we feel spirometry is of value in the management of AF-COPD. EXPERT OPINION: AF and COPD commonly co-occur, there is often diagnostic delay, increased risk of reduced cardioversion success, and missed opportunity to intervene to reduce stroke risk. Greater awareness and timelier diagnosis and guideline directed management may improve outcomes for people with both diseases.
Ioannides et al. (Tue,) conducted a review in Atrial fibrillation and COPD. Spirometry was evaluated. Atrial fibrillation and COPD commonly co-occur, and greater awareness, timelier diagnosis using spirometry, and guideline-directed management may improve outcomes for people with both diseases.